![Indranil Dey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Indranil Dey
Vorstandsvorsitzender bei BLUEJAY DIAGNOSTICS, INC.
Vermögen: 123 539 $ am 31.05.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Svetlana Dey | F | 52 |
Lana Management & Business Research International LLC
| 16 Jahre |
Douglas Wurth | M | 59 | - | |
Frederick Zeidman | M | 77 | 3 Jahre | |
Donald Chase | M | 77 | 7 Jahre | |
Gary Gemignani | M | 58 | 3 Jahre | |
Jason Cook | M | 42 | 3 Jahre | |
Kevin Vance | M | 67 | 3 Jahre | |
Les DeLuca | M | - | - | |
Christine Meskell | F | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Carter H. Eckert | M | 82 |
IMPATH, Inc.
| 1 Jahre |
Richard Rosenzweig | M | 57 |
IMPATH, Inc.
| 3 Jahre |
Wolfgang Rencken | M | 58 |
Definiens AG
![]() Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | 4 Jahre |
Thomas Colarusso | M | - |
Definiens AG
![]() Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | - |
James V. Agnello | M | 70 |
IMPATH, Inc.
| 1 Jahre |
David Bennett | M | - |
Definiens AG
![]() Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | - |
James Weisberger | M | 68 |
IMPATH, Inc.
| 4 Jahre |
Matthew Diaz | M | - |
IMPATH, Inc.
| 1 Jahre |
Frances Scally | F | 57 | 1 Jahre | |
Kenneth Fisher | M | 45 | 1 Jahre | |
Gordon Kinder | M | 44 | 1 Jahre | |
Edwin E. Rule | M | - | - | |
Burdick Julie-Ann | F | - | - | |
Ryan McSeveney | M | - | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 20 | 86,96% |
Deutschland | 3 | 13,04% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Indranil Dey
- Persönliches Netzwerk